AMICUS THERAPEUTICS, INC. - Director's Dealing 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2020-03-20

Reporting Person: Crowley John F (Director, Chairman & CEO)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-20	Common Stock	M	20000	$5.13	Acquired	938836	Direct
2020-03-20	Common Stock	S	20000	$9.00	Disposed	918836	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-20	Stock Options (right to buy)	$5.13	M	20000	Disposed	2027-01-03	Common Stock (20000)	Direct

Security	Shares	Ownership
Common Stock	64895	Indirect

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: As of March 20, 2020, 123,631 options were fully vested and exercisable and 58,854 remained unvested from this individual 2017 grant.